Edition:
United States

Oxford BioMedica PLC (OXB.L)

OXB.L on London Stock Exchange

4.80GBp
6:11am EDT
Change (% chg)

0.07 (+1.48%)
Prev Close
4.72
Open
4.94
Day's High
4.94
Day's Low
4.67
Volume
627,870
Avg. Vol
4,315,060
52-wk High
6.50
52-wk Low
2.98

OXB.L

Chart for OXB.L

About

Oxford BioMedica plc is a gene and cell therapy company. The Company is engaged in lentiviral vector and cell therapy research, development and production. The Company's segments include Partnering, and R&D. The Partnering segment provides lentiviral vector bioprocessing and process development services to partners. The R&D... (more)

Overall

Beta: 0.63
Market Cap(Mil.): £145.92
Shares Outstanding(Mil.): 3,088.27
Dividend: --
Yield (%): --

Financials

  OXB.L Industry Sector
P/E (TTM): -- 57.54 29.95
EPS (TTM): -0.01 -- --
ROI: -38.56 -0.41 13.21
ROE: -141.57 6.21 14.38

BRIEF-Oxford Biomedica notes acceptance by FDA of a biologics license application filing for CTL019

* Oxford Biomedica notes acceptance by FDA of a biologics license application (BLA) filing for CTL019

Mar 30 2017

BRIEF-Oxford biomedica says Trovax shown to induce beneficial anti-tumour immune responses

* Cyclophosphamide and Trovax independently shown to induce highly beneficial anti-tumour immune responses

Feb 24 2017

BRIEF-Oxford Biomedica inks strategic alliance with Orchard Therapeutics

* Oxford Biomedica announces a strategic alliance with Orchard Therapeutics

Nov 29 2016

More From Around the Web

Earnings vs. Estimates